Furthermore, we and others previously have shown that blockade of PlGF by specific antibody, small interfering RNA (siRNA), or genetic ablation suppressed liver fibrogenesis (22, 23), reduced portal hypertension (24) and inhibited HCC (18, 25, 26). This evidence concerns the gene PGF and hepatocellular carcinoma.